A national prospective cohort study of COVID-19 in children referred to hospitals. All patients under the age of 18 who present to participating hospitals with suspected COVID-19 may be included. Patients with confirmed COVID-19 will be compared to patients with disproved COVID-19. We will use WHO's ISARIC model protocol, developed specifically for such pandemics. We will record epidemiological risk factors, symptoms, clinical findings, results of blood tests, X-rays and other investigations, treatment measures, complications, mortality and measures at the hospital to prevent the spread of infection. Patients are summoned for follow-up examinations 2 and 6 months after the outbreak of illness. Biological material for biobanking is taken at all time points. Patients over the age of 10 will also fill out a questionnaire on inclusion and follow-up. The questionnaire includes questions about fatigue, as well as psychosocial conditions. Data from various Norwegian patient and quality registries will be sought to strengthen the study.
Observed reduction in the diagnosis of acute lymphoblastic leukaemia in children during the COVID-19 pandemic
Acta Paediatr (in press)
Lower ST-elevation myocardial infarction incidence during COVID-19 epidemic in Northern Europe
Scand Cardiovasc J, 1-3 (in press)
Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
Proc Natl Acad Sci U S A (in press)